Jan. 2, 2003 — The monoclonal antibody natalizumab reduces relapses of multiple sclerosis (MS) and increases rates of clinical remission for patients with Crohn's disease, according to the results of ...
Researchers at the University of California, San Diego (UCSD) School of Medicine have developed a mouse model that could help scientists develop better drugs to fight autoimmune and inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback